Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases

Neurodegenerative diseases (NDs), such as Alzheimer’s (AD), Parkinson’s (PD), and amyotrophic lateral sclerosis (ALS), share common pathological mechanisms, including metabolism alterations. However, their specific neuronal cell types affected and molecular biomarkers suggest that there are both com...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanznaster, Débora, Dingeo, Giulia, Samey, Rayhanatou Altine, Emond, Patrick, Blasco, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503806/
https://www.ncbi.nlm.nih.gov/pubmed/36144268
http://dx.doi.org/10.3390/metabo12090864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503806/
https://www.ncbi.nlm.nih.gov/pubmed/36144268
http://dx.doi.org/10.3390/metabo12090864

Ejemplares similares